SUDEEP PHARMA LIMITED Fair Value
SUDEEPPHRM · Chemicals · Current price ₹862.75
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹138 | 25% ROE fading to 12% over ~10 yrs, on ₹78 book |
| Relative P/E | ₹599 | EPS × 39.1 peer-median P/E |
| Graham floor | ₹164 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is SUDEEP PHARMA LIMITED undervalued?
DocStoX estimates the fair value of SUDEEP PHARMA LIMITED at ₹272 per share, versus the current market price of ₹863. That puts the stock about -68.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹138), Relative P/E (₹599), Graham floor (₹164). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹138 (bear) to ₹272 (base) to ₹599 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SUDEEP PHARMA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.